Robert Thong
Co-Founder & Chief Executive Officer MultiOmic Health
Robert Thong is Co-Founder and CEO of MultiOmic Health, a TechBio startup deploying AI-enabled computational biology on patient-derived data to stratify chronic disease patients and discover the corresponding drug targets and biomarkers. He has 35 years’ experience of business leadership and strategic advisory work with bioscience and healthcare organizations across Europe and the United States. Robert has been a board member of an NYSE-listed pharmaceutical company (Alpharma, acquired 2008 for $1.6 billion), led the life sciences divisions of major listed professional services organizations (CapGemini, Datamonitor), managed an R&D best practices consortium of European mid-sized pharmaceutical companies, and served as board member for various startups in bioinformatics and metabolic disease.
Seminars
- Explore how AI and machine learning are being appliedto target identification, protein engineering, and biomarkerdiscovery in CKD, with a focus on DKD
- Examine case studies and strategies from different labs and companies to understand the practical implementation andevolving performance of AI tools
- Discuss the integration of AI across preclinical and clinical stages to accelerate precision nephrology research and development
- Consider collaborative approaches and future frameworks, including shared strategies or white papers, to advance AI use in kidney disease drug discovery and beyond
